Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias



Status:Enrolling by invitation
Conditions:Atrial Fibrillation, Atrial Fibrillation, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:22 - Any
Updated:2/17/2019
Start Date:December 8, 2018
End Date:August 31, 2019

Use our guide to learn which trials are right for you!

This post-marketing study is conducted to characterize the ability of Apple Watch rhythm
analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical
evaluation among users who contact AppleCare.


Inclusion Criteria:

1. Possession of the following at time of eligibility screening:

- iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS
version used to complete screening eligibility.

- Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple
Watch model/watchOS paired with iPhone used to complete screening eligibility

2. At least one of the following by self-report before consent:

- Irregular Rhythm Notification

- ECG app classification of Atrial Fibrillation

- ECG app classification of Inconclusive defined as "Inconclusive," "Heart Rate
Over 120," or "Heart Rate Under 50"

3. Age ≥ 22 years at time of eligibility screening

4. Current resident of the United States at time of eligibility screening, and will
reside in the United States for the length of the study

5. Proficient in written and spoken English

6. Valid phone number associated with iPhone, ascertained from self-report

7. Valid email address, ascertained from self-report

Exclusion Criteria:

1. Shared iCloud account

2. Shared AppleWatch
We found this trial at
1
site
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials